Chryseobacterium/Elizabethkingia species infections in Saudi Arabia
- PMID: 32114605
- PMCID: PMC7841570
- DOI: 10.15537/smj.2020.3.24985
Chryseobacterium/Elizabethkingia species infections in Saudi Arabia
Abstract
Objectives: To describe the epidemiological, clinical, and outcome data of patients infected or colonized with Chryseobacterium/Elizabethkingia spp including antibiotic susceptibility patterns.
Methods: This retrospective study was conducted at Prince Sultan Military Medical City, Riyadh, Saudi Arabia. All patients infected or colonized by Chryseobacterium /Elizabethkingia spp who were admitted between June 2013 and May 2019 were included. Data were extracted from patient electronic medical records.
Results: We enrolled 27 patients (13 males and 14 females) with a mean age of 35.6 years. Chryseobacterium/Elizabethkingia spp were isolated from blood cultures (n=13, 48%) and tracheal aspirations (n=11, 41%). The most frequent species isolated was Elizabethkingia meningoseptica (n=22). Although 6 patients were considered colonized, the remaining 21 patients presented with ventilator associated pneumonia (n=9), central line associated bloodstream infection (n=4), septic shock (n=4), or isolated bacteremia (n=4). In 25 cases the infections were health-care related. Three patients (11%) died within 28 days. Twenty-six isolates (96.5%) were resistant to carbapenems. Moxifloxacin and cotrimoxazole were the most active antibiotics.
Conclusion: Chryseobacterium/Elizabethkingia spp infection is rare, but can be responsible for severe hospital acquired infections. Cotrimoxazole and fluoroquinolone are the most effective antibiotic treatments.
Figures
References
-
- Vandamme P, Bernardet J-F, Segers P, Kersters K, Holmes B. New perspectives in the classification of the flavobacteria:Description of Chryseobacterium gen. rev Int J Syst Bacteriol. 1994;44:827–831.
-
- Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt H W. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravenous device. Clin Microbiol Infect. 2001;7:391–393. - PubMed
-
- Mirza HC, Tuncer Ö, Ölmez S, Şener B, Tuğcu GD, Özçelik U, et al. clinical Strains of Chryseobacterium and Elizabethkingia spp isolated from pediatric patients in a university hospital:Performance of MALDI-TOF MS-based identification, antimicrobial susceptibilities, and baseline patient characteristics. Microb Drug Resist. 2018;24:816–821. - PubMed
-
- Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS. Clinical and epidemiological features of Chryseobacterium indologenes infections:Analysis of 215 cases. J Microbiol Immunol Infect. 2013;46:425–432. - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous
